Asian Gynecological Brachytherapy Registry in Cervical Cancer

What this Trial Is About

Gynecological cancer, particularly cervical cancer, is a significant health challenge in Asia, causing many deaths due to limited preventive care, screening, and cultural delays in seeking treatment. This research focuses on advanced cervical cancer patients treated with radiation and chemotherapy followed by internal radiation called brachytherapy. While advanced brachytherapy methods have shown good results in Western countries, there is a lack of data on their use and outcomes in Asian populations, leading to inconsistent treatment practices. The Asian Gynecological Brachytherapy Registry (ABGR) is a collaborative effort collecting data from multiple centers across Asia. It uses a retrospective cohort design to include patients treated over a 12-month period with different brachytherapy techniques and imaging methods. The registry also gathers information on external radiation, chemotherapy, treatment timing, patient demographics, and treatment planning variations. This comprehensive data aims to understand treatment patterns, outcomes, and factors influencing care across Asian healthcare settings. Participants' medical records will be reviewed to record the types of brachytherapy and radiation treatments used, chemotherapy doses, treatment schedules, and side effects over a three-year period. The study will measure outcomes such as local and regional cancer control, disease-free survival, and radiation-related adverse events. Data quality and patient privacy are maintained through strict protocols, and the findings will support future improvements in cervical cancer care in Asia.

Asian Gynecological Brachytherapy Registry in Cervical Cancer